STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
NRXP NRX PHARMACEUTICALS INCORPORATED StockScouter® Report
2
StockScouter® Score
NRX PHARMACEUTICALS INCORPORATED, a micro cap company in the healthcare sector, is expected to underperform the market over the next six months with higher than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- Moving average analysis for NRXP suggests strong price movement over the medium term. Positive
Concerns
- The most recent quarterly earnings report was significantly lower than analysts’ consensus forecast. Negative
- Short-term relative price momentum exhibits meaningful weakness. Negative
- The multi-period measure of relative price change and consistency is below average. Negative/Neutral
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be neutral, stocks will be , and healthcare stocks will be neutral.
Expected Risk/Return
Core Model Grades
F
N/A
N/A
D